Posts
May 12 2017
EG&S is representing Fig Publishing, Inc. in Fig’s ongoing, multiple securities offerings under the SEC’s amended Regulation A. Fig is a video game publisher that issues separate series of preferred stock to members of the public, with each series designed to pay dividends based on revenues earned from a separate video game. So far, Fig has sold three series of Regulation A “Fig Game Shares”.
May 11 2017
Client Alert: New York City Bans All Inquiries Regarding Salary Histories of Job Applicants
New York City has joined other states and cities across the country – including Massachusetts and Philadelphia – in banning employers from inquiring about a job candidate’s salary history. Per legislation signed on May 4, 2017 by New York City Mayor Bill DeBlasio, effective November 1, 2017, all employers in New York City, both public and private and regardless of size, may no longer:
(1) inquire about the salary history of an applicant for employment; or
(2) rely on the salary history of an applicant in determining that applicant’s salary at any stage in the employment process, unless the applicant “unprompted” and “willingly” discloses his or her prior salary information.Click here to read the alert.
May 11 2017
Amyris Inc. announced the closing of their Registered Direct offering in the amount of $87,343,875. EG&S acted as counsel to the Placement Agent.
May 03 2017
On April 26, 2017, the Appellate Division, Second Department issued a decision reversing the Surrogate of Rockland County who had previously granted petitioner’s motion for summary judgment against EGS client, Alfred Zucaro. In reversing, the Second Department also granted Mr. Zucaro summary judgment dismissing petitioner’s conversion cause of action against him.
James K. Landau, a member of the Firm, represented Mr. Zucaro in connection with the appeal. A copy of the decision can be found at http://law.justia.com/cases/new-york/appellate-division-second-department/2017/2015-02684.html.
May 01 2017
The Deal issued its quarterly PIPE league tables, revealing that 2017’s first quarter outperformed last year’s first quarter. Deals were up nearly 75% from the previous year to 367, while dollars raised were up almost 70% to $21.3 billion.
EG&S is top ranked. Click here to read the article.
May 01 2017
CytRx Corporation announced the closing of their Registered Direct in the amount of $15,000,000. EG&S acted as counsel to the Placement Agent.
April 28 2017
BioPharm X Corporation announced the closing of their Registered Direct offering in the amount of $5,000,001. EG&S acted as counsel to the lead Investor.
April 27 2017
Aeterna Zentaris Inc. announced the implementation of their At the Market offering in the amount of $6,944,000. EG&S acted as counsel to the Placement Agent.